NCT02268526 - Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 2, 2015

Primary Completion Date

December 7, 2016

Study Completion Date

December 7, 2016

Conditions

HCMV

Interventions

BIOLOGICAL

CSJ148

CSJ148 IV q 4weeks

DRUG

Placebo

Placebo IV q 4weeks

Trial Locations (17)

3000

Novartis Investigative Site, Leuven

10002

Novartis Investigative Site, Taipei

27710

Novartis Investigative Site, Durham

32610

Novartis Investigative Site, Gainesville

33305

Novartis Investigative Site, New Taipei City

40447

Novartis Investigative Site, Taichung

45147

Novartis Investigative Site, Essen

46107

Novartis Investigative Site, Beech Grove

77030

Novartis Investigative Site, Houston

91054

Novartis Investigative Site, Erlangen

93053

Novartis Investigative Site, Regensburg

94143

Novartis Investigative Site, San Francisco

97070

Novartis Investigative Site, Würzburg

119228

Novartis Investigative Site, Singapore

169608

Novartis Investigative Site, Singapore

06351

Novartis Investigative Site, Seoul

06591

Novartis Investigative Site, Seoul